Last update 08 Mar 2026

Huanke (Hebei) Biotechnology Co., Ltd.

Joint Venture Company | Subsidiary Company|2024|Hebei Sheng, China

Overview

Tags

Infectious Diseases
Prophylactic vaccine
Genetically engineered subunit vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Infectious Diseases1
Top 5 Drug TypeCount
Prophylactic vaccine1
Genetically engineered subunit vaccine1

Related

1
Drugs associated with Huanke (Hebei) Biotechnology Co., Ltd.
Recombinant Zoster Vaccine(CHO Cell)(Huapu)
Target-
Mechanism
Immunostimulants
Active Org.
Huapu Shijiazhuang Pharmaceutical Co., Ltd. [+1]
Originator Org.
Huapu Shijiazhuang Pharmaceutical Co., Ltd.
Active Indication
Herpes Zoster
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Huanke (Hebei) Biotechnology Co., Ltd.
ChiCTR2600119810
/ Not yet recruitingPhase 1IIT
Phase I Clinical Trial on the Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cell) in Subjects Aged 40 Years and Above
CTR20260418
/ Not yet recruitingPhase 1
重组带状疱疹疫苗（CHO细胞）在40周岁及以上人群中接种的安全性和免疫原性I期临床试验
[Translation] Phase I clinical trial of the safety and immunogenicity of recombinant zoster vaccine (CHO cells) in individuals aged 40 years and older.
100 Clinical Results associated with Huanke (Hebei) Biotechnology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Huanke (Hebei) Biotechnology Co., Ltd.
Login to view more data
100 Deals associated with Huanke (Hebei) Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Huanke (Hebei) Biotechnology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 21 Mar 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
1
1
Phase 1
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free